Jennifer L. Clark

Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC)

Andrew J. Piper-Valillo, Jennifer L. Clark, Jose Mercado-Matos et al. · PLoS ONE · 2019 · 30 citations · Full text

Tumor Biology, Insulin Signaling, Irs-2 Expression Levels +14

O-linked α2,3 sialylation defines stem cell populations in breast cancer

Melanie R. Walker, Hira Lal Goel, Dimpi Mukhopadhyay et al. · Science Advances · 2022 · 30 citations · Full text

Minimizing Barriers in Learning for On-Call Radiology Residents—End-to-End Web-Based Resident Feedback System

Hailey H. Choi, Jennifer L. Clark, Ann K. Jay et al. · Journal of Digital Imaging · 2017 · 26 citations · Full text

Nursing, E-learning, Learning Health Systems +7

Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study

Sinan Khadhouri, Kevin Gallagher, Kenneth R. MacKenzie et al. · European Urology Focus · 2022 · 25 citations · Full text

Urology, Urologic Cancer Epidemiology, Genitourinary Cancer +10

Differential involvement of the microtubule cytoskeleton in insulin receptor substrate 1 (IRS-1) and IRS-2 signaling to AKT determines the response to microtubule disruption in breast carcinoma cells

Jose Mercado-Matos, Jennifer L. Clark, Andrew J. Piper-Valillo et al. · Journal of Biological Chemistry · 2017 · 24 citations · Full text